These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 16651418)

  • 21. A context-specific role for retinoblastoma protein-dependent negative growth control in suppressing mammary tumorigenesis.
    Francis SM; Chakrabarti S; Dick FA
    PLoS One; 2011 Feb; 6(2):e16434. PubMed ID: 21364977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical cell cycle regulation promotes mammary stem cell expansion during mammary development and tumourigenesis.
    Fifield BA; Vusich J; Haberfellner E; Andrechek ER; Porter LA
    Breast Cancer Res; 2024 Jun; 26(1):106. PubMed ID: 38943151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new role of SNAI2 in postlactational involution of the mammary gland links it to luminal breast cancer development.
    Castillo-Lluva S; Hontecillas-Prieto L; Blanco-Gómez A; Del Mar Sáez-Freire M; García-Cenador B; García-Criado J; Pérez-Andrés M; Orfao A; Cañamero M; Mao JH; Gridley T; Castellanos-Martín A; Pérez-Losada J
    Oncogene; 2015 Sep; 34(36):4777-90. PubMed ID: 26096931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NEDD9 Overexpression Causes Hyperproliferation of Luminal Cells and Cooperates with HER2 Oncogene in Tumor Initiation: A Novel Prognostic Marker in Breast Cancer.
    Purazo ML; Ice RJ; Shimpi R; Hoenerhoff M; Pugacheva EN
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.
    Pradeep CR; Zeisel A; Köstler WJ; Lauriola M; Jacob-Hirsch J; Haibe-Kains B; Amariglio N; Ben-Chetrit N; Emde A; Solomonov I; Neufeld G; Piccart M; Sagi I; Sotiriou C; Rechavi G; Domany E; Desmedt C; Yarden Y
    Oncogene; 2012 Aug; 31(31):3569-83. PubMed ID: 22139081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.
    Ma Z; Parris AB; Howard EW; Shi Y; Yang S; Jiang Y; Kong L; Yang X
    Carcinogenesis; 2018 Oct; 39(10):1264-1273. PubMed ID: 30107476
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer Development.
    Pseftogas A; Xanthopoulos K; Siasiaridis A; Poutahidis T; Gonidas C; Tsingotjidou A; Hatzivassiliou E; Mosialos G
    Anticancer Res; 2024 May; 44(5):1885-1894. PubMed ID: 38677721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infiltrating Mast Cell-Mediated Stimulation of Estrogen Receptor Activity in Breast Cancer Cells Promotes the Luminal Phenotype.
    Majorini MT; Cancila V; Rigoni A; Botti L; Dugo M; Triulzi T; De Cecco L; Fontanella E; Jachetti E; Tagliabue E; Chiodoni C; Tripodo C; Colombo MP; Lecis D
    Cancer Res; 2020 Jun; 80(11):2311-2324. PubMed ID: 32179512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification and functional characterization of p130Cas as a substrate of protein tyrosine phosphatase nonreceptor 14.
    Zhang P; Guo A; Possemato A; Wang C; Beard L; Carlin C; Markowitz SD; Polakiewicz RD; Wang Z
    Oncogene; 2013 Apr; 32(16):2087-95. PubMed ID: 22710723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.
    Boggio K; Nicoletti G; Di Carlo E; Cavallo F; Landuzzi L; Melani C; Giovarelli M; Rossi I; Nanni P; De Giovanni C; Bouchard P; Wolf S; Modesti A; Musiani P; Lollini PL; Colombo MP; Forni G
    J Exp Med; 1998 Aug; 188(3):589-96. PubMed ID: 9687535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PtdIns(3,4,5)P
    Srijakotre N; Liu HJ; Nobis M; Man J; Yip HYK; Papa A; Abud HE; Anderson KI; Welch HCE; Tiganis T; Timpson P; McLean CA; Ooms LM; Mitchell CA
    Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28056-28067. PubMed ID: 33097662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conditional knockout of SHP2 in ErbB2 transgenic mice or inhibition in HER2-amplified breast cancer cell lines blocks oncogene expression and tumorigenesis.
    Zhao H; Martin E; Matalkah F; Shah N; Ivanov A; Ruppert JM; Lockman PR; Agazie YM
    Oncogene; 2019 Mar; 38(13):2275-2290. PubMed ID: 30467378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin receptor loss impairs mammary tumorigenesis in mice.
    Podmore L; Poloz Y; Iorio C; Mouaaz S; Nixon K; Smirnov P; McDonnell B; Lam S; Zhang B; Tharmapalan P; Sarkar S; Vyas F; Ennis M; Dowling R; Stambolic V
    Cell Rep; 2023 Nov; 42(11):113251. PubMed ID: 37913774
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SK4 channels modulate Ca
    Steudel FA; Mohr CJ; Stegen B; Nguyen HY; Barnert A; Steinle M; Beer-Hammer S; Koch P; Lo WY; Schroth W; Hoppe R; Brauch H; Ruth P; Huber SM; Lukowski R
    Mol Oncol; 2017 Sep; 11(9):1172-1188. PubMed ID: 28557306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ADAMTS18 deficiency associates extracellular matrix dysfunction with a higher risk of HER2-positive mammary tumorigenesis and metastasis.
    Nie J; Dang S; Zhu R; Lu T; Zhang W
    Breast Cancer Res; 2024 Jan; 26(1):19. PubMed ID: 38287441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model.
    Li W; Li S; Chen IX; Liu Y; Ramjiawan RR; Leung CH; Gerweck LE; Fukumura D; Loeffler JS; Jain RK; Duda DG; Huang P
    Radiat Oncol; 2021 Mar; 16(1):48. PubMed ID: 33663521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Silencing of the HER2/neu gene by siRNA inhibits proliferation and induces apoptosis in HER2/neu-overexpressing breast cancer cells.
    Faltus T; Yuan J; Zimmer B; Krämer A; Loibl S; Kaufmann M; Strebhardt K
    Neoplasia; 2004; 6(6):786-95. PubMed ID: 15720805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of the Par3 polarity protein promotes breast tumorigenesis and metastasis.
    McCaffrey LM; Montalbano J; Mihai C; Macara IG
    Cancer Cell; 2012 Nov; 22(5):601-14. PubMed ID: 23153534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammary-specific expression of Trim24 establishes a mouse model of human metaplastic breast cancer.
    Shah VV; Duncan AD; Jiang S; Stratton SA; Allton KL; Yam C; Jain A; Krause PM; Lu Y; Cai S; Tu Y; Zhou X; Zhang X; Jiang Y; Carroll CL; Kang Z; Liu B; Shen J; Gagea M; Manu SM; Huo L; Gilcrease M; Powell RT; Guo L; Stephan C; Davies PJ; Parker-Thornburg J; Lozano G; Behringer RR; Piwnica-Worms H; Chang JT; Moulder SL; Barton MC
    Nat Commun; 2021 Sep; 12(1):5389. PubMed ID: 34508101
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ets2-dependent stromal regulation of mouse mammary tumors.
    Man AK; Young LJ; Tynan JA; Lesperance J; Egeblad M; Werb Z; Hauser CA; Muller WJ; Cardiff RD; Oshima RG
    Mol Cell Biol; 2003 Dec; 23(23):8614-25. PubMed ID: 14612405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.